These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25220639)

  • 1. Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats.
    Xu QY; Liu YH; Zhang Q; Ma B; Yang ZD; Liu L; Yao D; Cui GB; Sun JJ; Wu ZM
    Acta Pharmacol Sin; 2014 Oct; 35(10):1265-73. PubMed ID: 25220639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats.
    Zhang Q; Wang GJ; A JY; Wu D; Zhu LL; Ma B; Du Y
    Acta Pharmacol Sin; 2009 Dec; 30(12):1674-87. PubMed ID: 19960012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.
    Sun JH; Liu X; Cong LX; Li H; Zhang CY; Chen JG; Wang CM
    Lipids Health Dis; 2017 Aug; 16(1):145. PubMed ID: 28764799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
    Vega GL; Ma PT; Cater NB; Filipchuk N; Meguro S; Garcia-Garcia AB; Grundy SM
    Am J Cardiol; 2003 Apr; 91(8):956-60. PubMed ID: 12686335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UPLC/Q-TOF-MS/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats.
    Yang B; Xuan S; Ruan Q; Jiang S; Cui H; Zhu L; Luo X; Jin J; Zhao Z
    J Ethnopharmacol; 2020 Jun; 256():112784. PubMed ID: 32222573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.
    Ma N; Liu X; Kong X; Li S; Jiao Z; Qin Z; Dong P; Yang Y; Li J
    Lipids Health Dis; 2017 Dec; 16(1):240. PubMed ID: 29228968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
    Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
    J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.
    Ellen RL; McPherson R
    Am J Cardiol; 1998 Feb; 81(4A):60B-65B. PubMed ID: 9526816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
    Ji H; Liu Y; He F; An R; Du Z
    J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.
    Adkins JC; Faulds D
    Drugs; 1997 Oct; 54(4):615-33. PubMed ID: 9339964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
    Shi S; Liu Z; Xue Z; Chen X; Chu Y
    J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UPLC-Q-TOF/MS-based urine and plasma metabonomics study on the ameliorative effects of aspirin eugenol ester in hyperlipidemia rats.
    Ma N; Karam I; Liu XW; Kong XJ; Qin Z; Li SH; Jiao ZH; Dong PC; Yang YJ; Li JY
    Toxicol Appl Pharmacol; 2017 Oct; 332():40-51. PubMed ID: 28733207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹H-NMR and MS based metabolomics study of the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet.
    Li ZY; Ding LL; Li JM; Xu BL; Yang L; Bi KS; Wang ZT
    PLoS One; 2015; 10(3):e0120950. PubMed ID: 25786031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intervention of Huayu Qutan Recipe on liver SREBP-2 signal pathway of hyperlipidemia rats of pi deficiency syndrome].
    Leng X; Jia LQ; Yang GL; Wang JY; Zhu ML; Wang Y; Xu Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):320-6. PubMed ID: 25951638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid-lowering effect and mechanism of Danhong Injection on hyperlipidemia rats based on lipid metabolism disorder].
    DU HX; Zhou HF; He Y; Wan HT; Yang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):3203-3210. PubMed ID: 32726030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR-based metabolomics highlights differences in plasma metabolites in pigs exhibiting diet-induced differences in adiposity.
    Jégou M; Gondret F; Lalande-Martin J; Tea I; Baéza E; Louveau I
    Eur J Nutr; 2016 Apr; 55(3):1189-99. PubMed ID: 25997692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Yacon root extract improves lipid metabolism in hyperlipidemic rats by inhibiting HMGCR expression and activating the PPAR
    Gong S; Yang J; Zhang J; Wu X; Jiang S; Zhang Y; Gong G; Wu N; Sun J; Wu Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1977-1983. PubMed ID: 38081618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Anti-hyperlipidemia Effects of Raw Polygonum multiflorum Extract in Vivo.
    Xian Z; Liu Y; Xu W; Duan F; Guo Z; Xiao H
    Biol Pharm Bull; 2017; 40(11):1839-1845. PubMed ID: 29093330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.